Trials / Conditions / Hyperbilirubinemia

Hyperbilirubinemia

29 registered clinical trials studyying Hyperbilirubinemia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial NCT07409194	Yuzuncu Yil University	N/A
Recruiting	A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images NCT06421844	Air Force Military Medical University, China	—
Completed	Effect of Vitamin-D as an Adjuvant to Phototherapy in Reduction of Indirect Serum Bilirubin NCT07098234	Muhammad Aamir Latif	N/A
Unknown	Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmaph NCT04897113	National Medical Research Center for Rehabilitation and Balneology	N/A
Withdrawn	Biomarker for Gilbert Disease (BioGilbert) NCT02712138	CENTOGENE GmbH Rostock	—
Terminated	Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirub NCT03564678	M.D. Anderson Cancer Center	Phase 2
Completed	Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants NCT03195998	Pediatrix	—
Completed	Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age NCT02774434	Draeger Medical Systems, Inc.	N/A
Completed	Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants NCT02691156	Stanford University	—
Completed	Point-of-Care System for Determination of Bilirubin Capacity in Neonates NCT02612207	Stanford University	—
Completed	Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns NCT02613676	University of Stellenbosch	N/A
Completed	Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department NCT02446951	Children's Hospitals and Clinics of Minnesota	—
Completed	High Intensity Phototherapy: Double vs. Single NCT02805296	Aalborg University Hospital	N/A
Unknown	Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants? NCT01944696	The University of Texas Health Science Center, Houston	N/A
Completed	Implementation of a Transcutaneous Bilirubinometer NCT01622699	Princess Amalia Children's Clinic	N/A
Completed	The Investigation of the Causes of Hepatic Dysfunction in the Postoperative Period During Open-heart Surgeries NCT04271098	Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital	—
Terminated	Conjugated Hyperbilirubinemia and Pulse Oximetry NCT00741117	Emory University	N/A
Terminated	Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn NCT01136577	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Comparative Study of Phototherapy for Hyperbilirubinemia NCT00635375	GE Healthcare	N/A
Completed	Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Inf NCT01550627	University of Jena	EARLY_Phase 1
Completed	Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates NCT00653874	All India Institute of Medical Sciences	Phase 3
Completed	Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease NCT00288600	Oswaldo Cruz Foundation	Phase 4
Completed	Improving Health Outcomes for New Mothers and Babies NCT00360204	Milton S. Hershey Medical Center	Phase 3
Completed	Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia NCT00383318	Pediatrix	—
Terminated	Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W) NCT02685189	InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company	—
Completed	Safety and Pharmacology of Stanate NCT00115544	InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company	Phase 2
Completed	Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia NCT00004381	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 2
Completed	Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns NCT00004382	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 2
No Longer Available	Compassionate Use of Stanate (TM) [Stannsoporfin] NCT00076960	InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company	—